GPR39 and hepatocellular carcinoma: Overall, we reported that miR‐1914 is decreased in HCC samples and cell lines, although miR‐1914 inhibits cell growth by directly targeting the GPR39‐mediated PI3K/AKT/mTOR signalling pathway.